This information was published on 2024-10-24T00:04:26 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2483827 (IR 1803447) |
| (220) |
02 Sep 2024
|
| (300) |
DK, 23 May 2024, VA 2024 00914
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of cardiovascular diseases, chronic kidney disease, heart failure and hypertension. |
| (540) | Zembrilio |
| (550) | Word |
| (730) |
Novo Nordisk A/S
|
Find out more about publications on the About page.